BBMC Endocrine Disorders4/2/2026Glucagon-like peptide-1 receptor agonists reduce major adverse cardiovascular events and worsening heart failure in patients with heart failure: an umbrella meta-analysisChangxin Sun·L. Liu·Yongfang Yuan·Xiaoya Li·Min Wu·Lanqing Hu·Chuchuan MengRead at BMC Endocrine DisordersTagsDiabetes Treatment and ManagementEndocrinology, Diabetes and Metabolism
